Mitochondrial translocator protein deficiency exacerbates pathology in acute experimental ulcerative colitis

• Published in: Frontiers in physiology Vol. 13; p. 896951
• Main Authors: Jimenez, Isabel A, Stilin, Allison P, Morohaku, Kanako, Hussein, Mahmoud H, Koganti, Prasanthi P, Selvaraj, Vimal
• Format: Journal Article
• Language: English
• Published: Switzerland Frontiers Media S.A 19.08.2022
• Subjects: colon; inflammation; intestinal epithelium; mast cell; mitochondria; Physiology; colon; mast cell; intestinal epithelium; inflammation; mitochondria
• ISSN: 1664-042X; 1664-042X
• DOI: 10.3389/fphys.2022.896951

In human patients and animal models of ulcerative colitis (UC), upregulation of the mitochondrial translocator protein (TSPO) in the colon is consistent with inflammation. Although the molecular function for TSPO remains unclear, it has been investigated as a therapeutic target for ameliorating UC pathology. In this study, we examined the susceptibility of gene-deleted ( ) mice to insults as provided by the dextran sodium sulfate (DSS)-induced acute UC model. Our results show that UC clinical signs and pathology were severely exacerbated in mice compared to control cohorts. Histopathology showed extensive inflammation and epithelial loss in mice that caused an aggravated disease. Colonic gene expression in UC uncovered an etiology linked to precipitous loss of epithelial integrity and disproportionate mast cell activation assessed by tryptase levels in colons. Evaluation of baseline homeostatic shifts in colons revealed gene expression changes noted in elevated epithelial , mast cell and , with general indicators of lower proliferation capacity and elevated mitochondrial fatty acid oxidation. These findings demonstrate that intact physiological TSPO function serves to limit inflammation in acute UC, and provide a systemic basis for investigating TSPO-targeting mechanistic therapeutics.